GIinteractive11 | Case 12 - Pancreatic Cancer


An otherwise healthy 44-year-old woman with prior removal of primary pancreatic cancer and one small liver met now has multiple recurrent liver metastases and elevated tumor markers.

What is your most common treatment recommendation?

If this patient received FOLFIRINOX and experienced stable/responding disease for eight cycles but then developed disease progression, what would most likely be your next off-protocol systemic therapy?